Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Non-Standardized Pollen Allergenic Extract [EPC]
Triticum Aestivum Pollen is a non-standardized allergenic extract used in the diagnosis and treatment of IgE-mediated wheat pollen allergies via skin testing and immunotherapy.
Name
Triticum Aestivum Pollen
Raw Name
TRITICUM AESTIVUM POLLEN
Category
Non-Standardized Pollen Allergenic Extract [EPC]
Drug Count
21
Variant Count
22
Last Verified
February 17, 2026
About Triticum Aestivum Pollen
Triticum Aestivum Pollen is a non-standardized allergenic extract used in the diagnosis and treatment of IgE-mediated wheat pollen allergies via skin testing and immunotherapy.
Detailed information about Triticum Aestivum Pollen
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Triticum Aestivum Pollen.
The FDA has a long history of regulating allergenic extracts, many of which were introduced before modern standardized testing protocols were established. Because this specific extract is 'non-standardized,' its potency is not measured in Bioequivalent Allergy Units (BAU) but is instead typically expressed in Protein Nitrogen Units (PNU) or as a weight-to-volume (w/v) ratio. It is primarily indicated for patients who exhibit symptoms of allergic rhinitis (hay fever), allergic conjunctivitis, or seasonal asthma when exposed to wheat fields or agricultural environments during the pollination season.
The mechanism of Triticum Aestivum Pollen depends on whether it is being used for diagnosis or treatment. At the molecular level, the extract contains specific antigens (allergens) that are recognized by the immune system of sensitized individuals.
Diagnostic Mechanism: When used for skin testing (prick or intradermal), the allergens in the extract cross-link with specific Immunoglobulin E (IgE) antibodies bound to the surface of mast cells in the skin. This cross-linking triggers the degranulation of mast cells, releasing inflammatory mediators such as histamine, leukotrienes, and prostaglandins. This results in a 'wheal and flare' reaction—a localized swelling and redness—that confirms the patient's sensitivity to wheat pollen.
Therapeutic Mechanism (Immunotherapy): When administered as subcutaneous immunotherapy (SCIT), the goal is to induce 'immune tolerance.' Repeated exposure to increasing doses of the pollen extract shifts the immune response from a Th2-dominated profile (which produces IgE) to a Th1-dominated profile. This process increases the production of 'blocking antibodies' (IgG4) and stimulates the activity of regulatory T-cells (Tregs). Over time, this reduces the sensitivity of mast cells and basophils, leading to a significant decrease in allergic symptoms upon natural exposure to wheat pollen.
As a biological allergenic extract consisting of various proteins, the traditional pharmacokinetic parameters (absorption, distribution, metabolism, excretion) used for small-molecule drugs do not apply in the conventional sense.
Triticum Aestivum Pollen is FDA-approved for the following clinical applications:
Off-label uses are rare, though some clinicians may use these extracts in research settings to study cross-reactivity between different cereal grain pollens (e.g., rye, barley, and oats), which often share similar antigenic structures.
Triticum Aestivum Pollen is available in several concentrated liquid forms, typically supplied in multi-dose vials:
> Important: Only your healthcare provider, typically an allergist or immunologist, can determine if Triticum Aestivum Pollen is right for your specific condition. The selection of the extract and the concentration used must be tailored to your individual sensitivity levels.
Dosage for Triticum Aestivum Pollen is highly individualized and is never a 'one-size-fits-all' regimen. Because the extract is non-standardized, clinicians must refer to the specific PNU or w/v concentration provided by the manufacturer.
Triticum Aestivum Pollen is used in children, but extreme caution is required. There is no specific age-based dosage; rather, the dose is determined by the child's level of sensitivity, similar to adults. Pediatric patients are at a higher risk for systemic reactions if they have poorly controlled asthma. Most allergists avoid starting immunotherapy in children under the age of 5 due to the difficulty of communicating symptoms of impending anaphylaxis.
No dosage adjustments are required for patients with renal impairment, as the proteins are not cleared by the kidneys in a manner that would lead to toxicity.
No dosage adjustments are required for patients with hepatic impairment.
Elderly patients (over 65) require careful evaluation of their cardiovascular status. If an elderly patient is taking beta-blockers for hypertension or heart disease, they may be ineligible for immunotherapy because these drugs can interfere with the effectiveness of epinephrine if an allergic emergency occurs.
This medication is never self-administered by the patient at home. It must be administered in a clinical setting (such as an allergist's office) equipped with emergency supplies, including oxygen, IV fluids, and epinephrine.
If a maintenance dose is missed, the next dose may need to be reduced depending on how much time has elapsed. For example, if a dose is missed by more than 2 weeks, the allergist may drop the dose back by one or two levels to ensure safety and prevent a systemic reaction upon re-exposure.
An 'overdose' in the context of allergenic extracts usually means the administration of a dose that exceeds the patient's current tolerance level. Signs of overdose include:
In the event of an overdose/systemic reaction, the immediate administration of intramuscular epinephrine is the primary treatment, followed by antihistamines and corticosteroids as needed.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not attempt to alter the schedule or skip the observation period without medical guidance.
Most patients undergoing skin testing or immunotherapy with Triticum Aestivum Pollen will experience local reactions. These are generally not dangerous but indicate the body's immune response to the allergen.
> Warning: Stop the administration process and call for emergency medical help immediately if you experience any of the following symptoms of anaphylaxis:
There are no known long-term 'toxic' effects of Triticum Aestivum Pollen. Unlike many pharmacological drugs, allergenic extracts do not damage organs like the liver or kidneys over time. The primary long-term risk is the development of a new sensitivity to other components in the extract, though this is rare. Most long-term effects are positive, resulting in a permanent or semi-permanent reduction in allergy symptoms and a decreased risk of developing asthma.
Allergenic extracts, including Triticum Aestivum Pollen, carry a significant warning regarding the risk of Anaphylaxis.
Summary of Warning: This product can cause severe, life-threatening systemic reactions, including anaphylaxis. It must only be administered by healthcare professionals prepared to treat such reactions. Patients with unstable asthma are at a significantly higher risk of fatal outcomes. Patients must be observed for at least 30 minutes after each dose. Patients should be prescribed and trained on the use of an epinephrine auto-injector for use in case of a delayed reaction after leaving the clinic.
Report any unusual symptoms, especially those occurring hours after your appointment, to your healthcare provider immediately.
Triticum Aestivum Pollen is a potent biological agent. Its use is restricted to diagnostic and therapeutic protocols under the supervision of specialists. The most critical safety consideration is the prevention and management of systemic allergic reactions. Patients must be in their baseline state of health (no active infections or asthma flares) before receiving an injection.
No FDA black box warnings for Triticum Aestivum Pollen exist in the same format as small-molecule drugs (like antidepressants), but the General Warning for Allergenic Extracts is equivalent in severity. It emphasizes that these extracts can cause severe anaphylaxis and must be administered in a facility with emergency equipment. It also highlights that patients with severe or poorly controlled asthma should not receive immunotherapy due to the risk of fatal bronchospasm.
Generally, Triticum Aestivum Pollen does not cause sedation. However, if a patient experiences a systemic reaction or receives epinephrine, they should not drive or operate machinery until they have fully recovered and been cleared by a physician.
Patients are generally advised to avoid alcohol for several hours before and after an injection. Alcohol can cause vasodilation, which may potentially increase the rate of allergen absorption or worsen the severity of an allergic reaction.
Immunotherapy can be discontinued at any time, but the benefits of desensitization will be lost if the maintenance phase is not completed (usually 3–5 years). There is no 'withdrawal syndrome' associated with stopping pollen extracts.
> Important: Discuss all your medical conditions, especially respiratory or heart issues, with your healthcare provider before starting Triticum Aestivum Pollen.
There are no absolute drug-drug contraindications that prevent the use of Triticum Aestivum Pollen, but certain combinations significantly increase the risk of a poor outcome during a reaction.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, especially those for blood pressure or depression.
There are several scenarios where Triticum Aestivum Pollen must NEVER be used:
These conditions require a careful risk-benefit analysis by the allergist:
Patients allergic to Triticum Aestivum Pollen often show cross-sensitivity to other members of the Poaceae (grass) family. This includes:
Because of these shared proteins, a patient may react to a 'Grass Mix' extract even if wheat pollen is the primary trigger.
> Important: Your healthcare provider will evaluate your complete medical history and current respiratory health before prescribing Triticum Aestivum Pollen.
Pregnancy Category C: Animal reproduction studies have not been conducted with Triticum Aestivum Pollen. The primary concern during pregnancy is not the extract itself, but the potential for a systemic reaction (anaphylaxis) in the mother. Anaphylaxis can cause a sudden drop in blood pressure and uterine contractions, leading to fetal hypoxia (lack of oxygen) or miscarriage.
It is not known whether the allergenic components of Triticum Aestivum Pollen are excreted in human milk. However, since these are proteins that are digested in the infant's gut, the risk to a nursing infant is considered negligible. Breastfeeding is not a contraindication for receiving allergy shots.
Triticum Aestivum Pollen is used in children to treat allergic rhinitis and asthma. Clinical studies have shown that immunotherapy can prevent the 'allergic march'—the progression from hay fever to asthma in children. However, the child must be old enough to communicate symptoms. The safety profile in children is similar to adults, provided the asthma is well-controlled.
Patients over 65 may have a higher prevalence of cardiovascular disease, which increases the risk associated with anaphylaxis. Additionally, the elderly are more likely to be on multiple medications (polypharmacy), such as beta-blockers or ACE inhibitors, which complicate the management of allergic reactions. A thorough cardiac evaluation is recommended for older adults before starting Triticum Aestivum Pollen.
There is no evidence that renal impairment affects the safety or efficacy of Triticum Aestivum Pollen. The proteins are broken down locally and systemically by proteases and do not rely on renal filtration for clearance.
No specific studies have been performed in patients with hepatic impairment. However, since the metabolism of allergenic proteins is not dependent on the cytochrome P450 system or other hepatic pathways, no dosage adjustments are anticipated.
> Important: Special populations, particularly pregnant women and those with heart disease, require individualized medical assessment by a board-certified allergist.
Triticum Aestivum Pollen works through the principles of Type I Hypersensitivity and Immunological Desensitization.
| Parameter | Value |
|---|---|
| Bioavailability | N/A (Subcutaneous injection) |
| Protein Binding | N/A (Proteins are the active agents) |
| Half-life | Variable (Proteolysis occurs within hours to days) |
| Tmax | 30–60 minutes (for systemic absorption of proteins) |
| Metabolism | Proteolysis by lysosomal enzymes |
| Excretion | Not renally excreted as intact protein |
Triticum Aestivum Pollen is a Non-Standardized Pollen Allergenic Extract. It belongs to the broader therapeutic category of Allergenics. Related medications include other grass pollen extracts like Timothy Grass (Phleum pratense) and Orchard Grass (Dactylis glomerata).
Common questions about Triticum Aestivum Pollen
Triticum Aestivum Pollen, or common wheat pollen, is primarily used by allergists to diagnose and treat wheat pollen allergies. In the diagnostic phase, it is used in skin prick tests to see if a patient develops a localized allergic reaction. For treatment, it is used in allergen immunotherapy, commonly known as allergy shots. This involves giving gradually increasing doses of the pollen extract to desensitize the immune system. Over time, this reduces the severity of symptoms like sneezing, itchy eyes, and asthma when the patient is exposed to wheat pollen in nature.
The most common side effects are local reactions at the site of the skin test or injection. These include redness, itching, and a small raised bump called a wheal, which typically disappears within a few hours. Some patients receiving allergy shots may experience larger areas of swelling or 'knots' under the skin that can last for a day or two. While rare, systemic reactions like hives, wheezing, or a full-body allergic response can occur. Because of this, patients must always be monitored for 30 minutes after receiving an injection in a medical facility.
It is generally recommended to avoid alcohol on the days you receive an injection of Triticum Aestivum Pollen. Alcohol causes the blood vessels to dilate (expand), which can potentially speed up the absorption of the pollen extract into your bloodstream. This could increase the risk of a systemic allergic reaction or make a reaction more severe if it occurs. Additionally, alcohol can mask some of the early warning signs of an allergic reaction, such as flushing or lightheadedness. Always check with your allergist for their specific policy regarding alcohol use during immunotherapy.
Triticum Aestivum Pollen is generally not started during pregnancy because of the risk of a severe allergic reaction, which could be dangerous for the developing baby. However, if a woman is already on a stable maintenance dose of allergy shots and becomes pregnant, many allergists will allow her to continue the treatment. The main goal is to avoid any reaction that could cause a drop in the mother's blood pressure or oxygen levels. If you are planning to become pregnant or find out you are pregnant while on immunotherapy, you must inform your doctor immediately to discuss the safest path forward.
The diagnostic skin test works almost immediately, with results visible in about 15 to 20 minutes. However, for the treatment of allergies (immunotherapy), it takes much longer to see a clinical benefit. Most patients begin to notice a reduction in their allergy symptoms after 6 to 12 months of consistent weekly or bi-weekly injections. The full benefit of the treatment is typically reached after the patient has been on a 'maintenance dose' for several months. A full course of treatment usually lasts 3 to 5 years to ensure long-lasting relief.
Yes, you can stop taking Triticum Aestivum Pollen injections at any time without experiencing withdrawal symptoms like you might with some other medications. However, stopping the treatment before the recommended 3-to-5-year period usually means your allergy symptoms will eventually return. Immunotherapy works by gradually retraining your immune system, and this process requires long-term consistency. If you need to stop treatment due to side effects, cost, or travel, discuss a tapering plan or alternative treatments with your allergist first.
If you miss a scheduled allergy shot, you should contact your allergist's office to reschedule as soon as possible. Do not simply wait for your next appointment without calling, as the timing of the doses is critical for safety. If too much time passes between injections (usually more than 1–2 weeks past the due date), your doctor may need to reduce your dose for the next injection to prevent an allergic reaction. This ensures that your body is not 'surprised' by a high dose of allergen after a long break.
There is no scientific evidence to suggest that Triticum Aestivum Pollen allergenic extracts cause weight gain. Unlike systemic corticosteroids (like prednisone), which are sometimes used to treat severe allergies and are known to cause weight changes, pollen extracts are proteins that work locally on the immune system. They do not affect your metabolism, appetite, or fat storage. If you notice weight changes while on immunotherapy, it is likely due to other factors or medications, and you should discuss this with your primary care physician.
Triticum Aestivum Pollen can be taken with most medications, but there are some very important exceptions. You must tell your doctor if you are taking beta-blockers, ACE inhibitors, or MAO inhibitors, as these can make allergic reactions more dangerous or harder to treat. Additionally, you must stop taking antihistamines for several days before a skin test, as they will block the reaction and lead to inaccurate results. Most other routine medications for cholesterol, diabetes, or birth control do not interact with allergy shots.
The concept of 'generic' versus 'brand name' is slightly different for allergenic extracts than for pills. Triticum Aestivum Pollen is produced by several different biological laboratories (such as Greer, ALK, or HollisterStier). While the active ingredient is the same (wheat pollen), these products are 'non-standardized,' meaning the exact protein concentration can vary between manufacturers. Therefore, they are not considered interchangeable in the same way generic ibuprofen is. If your doctor switches manufacturers, they will usually restart or reduce your dose to ensure safety.